APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical BPO Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical BPO Service Market Outlook and Growth Opportunities 2026

Report ID 17421420042 May 2026197 pages

Choose your research edition.

Industry ResearchPharmaceutical BPO Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical BPO Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical BPO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical BPO Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical BPO Service Market Analysis and Forecast 2026-2032255 pages · $4,950 USD

Market perspective

The global Pharmaceutical BPO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical BPO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical BPO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical BPO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical BPO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical BPO Service market include Canon Business Process Services, Eminenture, Tracekey Solutions, Pharmbills, WNS, Accenture, Sutherlan, TCS and Cognizant, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical BPO Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical BPO Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical BPO Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical BPO Service market.

Pharmaceutical BPO Service Segment by Company

Canon Business Process Services

Eminenture

Tracekey Solutions

Pharmbills

WNS

Accenture

Sutherlan

TCS

Cognizant

Qol Holdings

Inventiv

Catalent

Parexel

Lonza

Boehringer Ingelheim

Charles Rivers

Genpact

Pharmaceutical BPO Service Segment by Type

On-Site Service

Off-Site Service

Pharmaceutical BPO Service Segment by Application

Contract Research Organizations

Contract Manufacturing Organizations

Contract Sales and Marketing Organizations

Others

Pharmaceutical BPO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical BPO Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical BPO Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical BPO Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical BPO Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical BPO Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical BPO Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical BPO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical BPO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical BPO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical BPO Service industry.

Chapter 3: Detailed analysis of Pharmaceutical BPO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical BPO Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical BPO Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical BPO Service Industry Trends Table 2. Pharmaceutical BPO Service Industry Drivers Table 3. Pharmaceutical BPO Service Industry Opportunities and Challenges Table 4. Pharmaceutical BPO Service Industry Restraints Table 5. Global Pharmaceutical BPO Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical BPO Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical BPO Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical BPO Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical BPO Service Company, Product Type & Application Table 10. Global Pharmaceutical BPO Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical BPO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-Site Service Table 15. Significant Companies of Off-Site Service Table 16. Global Pharmaceutical BPO Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmaceutical BPO Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pharmaceutical BPO Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pharmaceutical BPO Service Sales Value Share by Type (2021-2026) Table 20. Global Pharmaceutical BPO Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Contract Research Organizations Table 22. Significant Companies of Contract Manufacturing Organizations Table 23. Significant Companies of Contract Sales and Marketing Organizations Table 24. Significant Companies of Others Table 25. Global Pharmaceutical BPO Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical BPO Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical BPO Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical BPO Service Sales Value Share by Application (2021-2026) Table 29. Global Pharmaceutical BPO Service Sales Value Share by Application (2027-2032) Table 30. Global Pharmaceutical BPO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical BPO Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical BPO Service Sales Value Share by Region (2021-2026) Table 33. Global Pharmaceutical BPO Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical BPO Service Sales Value Share by Region (2027-2032) Table 35. Global Pharmaceutical BPO Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pharmaceutical BPO Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pharmaceutical BPO Service Sales Value Market Share by Country (2021-2026) Table 38. Global Pharmaceutical BPO Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pharmaceutical BPO Service Sales Value Market Share by Country (2027-2032) Table 40. Canon Business Process Services Company Information Table 41. Canon Business Process Services Business Overview Table 42. Canon Business Process Services Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Canon Business Process Services Pharmaceutical BPO Service Product Portfolio Table 44. Canon Business Process Services Recent Development Table 45. Eminenture Company Information Table 46. Eminenture Business Overview Table 47. Eminenture Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Eminenture Pharmaceutical BPO Service Product Portfolio Table 49. Eminenture Recent Development Table 50. Tracekey Solutions Company Information Table 51. Tracekey Solutions Business Overview Table 52. Tracekey Solutions Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Tracekey Solutions Pharmaceutical BPO Service Product Portfolio Table 54. Tracekey Solutions Recent Development Table 55. Pharmbills Company Information Table 56. Pharmbills Business Overview Table 57. Pharmbills Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Pharmbills Pharmaceutical BPO Service Product Portfolio Table 59. Pharmbills Recent Development Table 60. WNS Company Information Table 61. WNS Business Overview Table 62. WNS Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. WNS Pharmaceutical BPO Service Product Portfolio Table 64. WNS Recent Development Table 65. Accenture Company Information Table 66. Accenture Business Overview Table 67. Accenture Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Accenture Pharmaceutical BPO Service Product Portfolio Table 69. Accenture Recent Development Table 70. Sutherlan Company Information Table 71. Sutherlan Business Overview Table 72. Sutherlan Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sutherlan Pharmaceutical BPO Service Product Portfolio Table 74. Sutherlan Recent Development Table 75. TCS Company Information Table 76. TCS Business Overview Table 77. TCS Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. TCS Pharmaceutical BPO Service Product Portfolio Table 79. TCS Recent Development Table 80. Cognizant Company Information Table 81. Cognizant Business Overview Table 82. Cognizant Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Cognizant Pharmaceutical BPO Service Product Portfolio Table 84. Cognizant Recent Development Table 85. Qol Holdings Company Information Table 86. Qol Holdings Business Overview Table 87. Qol Holdings Pharmaceutical BPO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Qol Holdings Pharmaceutical BPO Service Product Portfolio Table 89. Qol Holdings Recent Development Table 90. Inventiv Company Information Table 91. Inventiv Business Overview Table 92. Inventiv Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Inventiv Pharmaceutical BPO Service Product Portfolio Table 94. Inventiv Recent Development Table 95. Catalent Company Information Table 96. Catalent Business Overview Table 97. Catalent Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Catalent Pharmaceutical BPO Service Product Portfolio Table 99. Catalent Recent Development Table 100. Parexel Company Information Table 101. Parexel Business Overview Table 102. Parexel Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Parexel Pharmaceutical BPO Service Product Portfolio Table 104. Parexel Recent Development Table 105. Lonza Company Information Table 106. Lonza Business Overview Table 107. Lonza Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Lonza Pharmaceutical BPO Service Product Portfolio Table 109. Lonza Recent Development Table 110. Boehringer Ingelheim Company Information Table 111. Boehringer Ingelheim Business Overview Table 112. Boehringer Ingelheim Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Boehringer Ingelheim Pharmaceutical BPO Service Product Portfolio Table 114. Boehringer Ingelheim Recent Development Table 115. Charles Rivers Company Information Table 116. Charles Rivers Business Overview Table 117. Charles Rivers Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Charles Rivers Pharmaceutical BPO Service Product Portfolio Table 119. Charles Rivers Recent Development Table 120. Genpact Company Information Table 121. Genpact Business Overview Table 122. Genpact Pharmaceutical BPO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Genpact Pharmaceutical BPO Service Product Portfolio Table 124. Genpact Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Pharmaceutical BPO Service Product Image Figure 2. Global Pharmaceutical BPO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical BPO Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical BPO Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-Site Service Image Figure 8. Off-Site Service Image Figure 9. Global Pharmaceutical BPO Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmaceutical BPO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pharmaceutical BPO Service Sales Value Share by Type (2021-2032) Figure 12. Contract Research Organizations Image Figure 13. Contract Manufacturing Organizations Image Figure 14. Contract Sales and Marketing Organizations Image Figure 15. Others Image Figure 16. Global Pharmaceutical BPO Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceutical BPO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical BPO Service Sales Value Share by Application (2021-2032) Figure 19. Global Pharmaceutical BPO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharmaceutical BPO Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pharmaceutical BPO Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pharmaceutical BPO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pharmaceutical BPO Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pharmaceutical BPO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pharmaceutical BPO Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pharmaceutical BPO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pharmaceutical BPO Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pharmaceutical BPO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pharmaceutical BPO Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pharmaceutical BPO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • On-Site Service
  • Off-Site Service
Applications
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Contract Sales and Marketing Organizations
  • Others
Companies covered
  • Canon Business Process Services
  • Eminenture
  • Tracekey Solutions
  • Pharmbills
  • WNS
  • Accenture
  • Sutherlan
  • TCS
  • Cognizant
  • Qol Holdings
  • Inventiv
  • Catalent
  • Parexel
  • Lonza
  • Boehringer Ingelheim
  • Charles Rivers
  • Genpact

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical BPO Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical BPO Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical BPO Service Market Dynamics
  1. 2.1 Pharmaceutical BPO Service Industry Trends
  2. 2.2 Pharmaceutical BPO Service Industry Drivers
  3. 2.3 Pharmaceutical BPO Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical BPO Service Industry Restraints
3 Pharmaceutical BPO Service Market by Company
  1. 3.1 Global Pharmaceutical BPO Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical BPO Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical BPO Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical BPO Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical BPO Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical BPO Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical BPO Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical BPO Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical BPO Service Market by Type
  1. 4.1 Pharmaceutical BPO Service Type Introduction
  2. 4.1.1 On-Site Service
  3. 4.1.2 Off-Site Service
  4. 4.2 Global Pharmaceutical BPO Service Sales Value by Type
  5. 4.2.1 Global Pharmaceutical BPO Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical BPO Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical BPO Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical BPO Service Market by Application
  1. 5.1 Pharmaceutical BPO Service Application Introduction
  2. 5.1.1 Contract Research Organizations
  3. 5.1.2 Contract Manufacturing Organizations
  4. 5.1.3 Contract Sales and Marketing Organizations
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical BPO Service Sales Value by Application
  7. 5.2.1 Global Pharmaceutical BPO Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical BPO Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical BPO Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical BPO Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical BPO Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical BPO Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical BPO Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical BPO Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical BPO Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical BPO Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical BPO Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical BPO Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical BPO Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical BPO Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical BPO Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical BPO Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical BPO Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical BPO Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical BPO Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical BPO Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical BPO Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical BPO Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical BPO Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical BPO Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical BPO Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical BPO Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Canon Business Process Services
  2. 8.1.1 Canon Business Process Services Company Information
  3. 8.1.2 Canon Business Process Services Business Overview
  4. 8.1.3 Canon Business Process Services Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Canon Business Process Services Pharmaceutical BPO Service Product Portfolio
  6. 8.1.5 Canon Business Process Services Recent Developments
  7. 8.2 Eminenture
  8. 8.2.1 Eminenture Company Information
  9. 8.2.2 Eminenture Business Overview
  10. 8.2.3 Eminenture Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eminenture Pharmaceutical BPO Service Product Portfolio
  12. 8.2.5 Eminenture Recent Developments
  13. 8.3 Tracekey Solutions
  14. 8.3.1 Tracekey Solutions Company Information
  15. 8.3.2 Tracekey Solutions Business Overview
  16. 8.3.3 Tracekey Solutions Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tracekey Solutions Pharmaceutical BPO Service Product Portfolio
  18. 8.3.5 Tracekey Solutions Recent Developments
  19. 8.4 Pharmbills
  20. 8.4.1 Pharmbills Company Information
  21. 8.4.2 Pharmbills Business Overview
  22. 8.4.3 Pharmbills Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmbills Pharmaceutical BPO Service Product Portfolio
  24. 8.4.5 Pharmbills Recent Developments
  25. 8.5 WNS
  26. 8.5.1 WNS Company Information
  27. 8.5.2 WNS Business Overview
  28. 8.5.3 WNS Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WNS Pharmaceutical BPO Service Product Portfolio
  30. 8.5.5 WNS Recent Developments
  31. 8.6 Accenture
  32. 8.6.1 Accenture Company Information
  33. 8.6.2 Accenture Business Overview
  34. 8.6.3 Accenture Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Accenture Pharmaceutical BPO Service Product Portfolio
  36. 8.6.5 Accenture Recent Developments
  37. 8.7 Sutherlan
  38. 8.7.1 Sutherlan Company Information
  39. 8.7.2 Sutherlan Business Overview
  40. 8.7.3 Sutherlan Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sutherlan Pharmaceutical BPO Service Product Portfolio
  42. 8.7.5 Sutherlan Recent Developments
  43. 8.8 TCS
  44. 8.8.1 TCS Company Information
  45. 8.8.2 TCS Business Overview
  46. 8.8.3 TCS Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TCS Pharmaceutical BPO Service Product Portfolio
  48. 8.8.5 TCS Recent Developments
  49. 8.9 Cognizant
  50. 8.9.1 Cognizant Company Information
  51. 8.9.2 Cognizant Business Overview
  52. 8.9.3 Cognizant Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cognizant Pharmaceutical BPO Service Product Portfolio
  54. 8.9.5 Cognizant Recent Developments
  55. 8.10 Qol Holdings
  56. 8.10.1 Qol Holdings Company Information
  57. 8.10.2 Qol Holdings Business Overview
  58. 8.10.3 Qol Holdings Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qol Holdings Pharmaceutical BPO Service Product Portfolio
  60. 8.10.5 Qol Holdings Recent Developments
  61. 8.11 Inventiv
  62. 8.11.1 Inventiv Company Information
  63. 8.11.2 Inventiv Business Overview
  64. 8.11.3 Inventiv Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Inventiv Pharmaceutical BPO Service Product Portfolio
  66. 8.11.5 Inventiv Recent Developments
  67. 8.12 Catalent
  68. 8.12.1 Catalent Company Information
  69. 8.12.2 Catalent Business Overview
  70. 8.12.3 Catalent Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Catalent Pharmaceutical BPO Service Product Portfolio
  72. 8.12.5 Catalent Recent Developments
  73. 8.13 Parexel
  74. 8.13.1 Parexel Company Information
  75. 8.13.2 Parexel Business Overview
  76. 8.13.3 Parexel Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Parexel Pharmaceutical BPO Service Product Portfolio
  78. 8.13.5 Parexel Recent Developments
  79. 8.14 Lonza
  80. 8.14.1 Lonza Company Information
  81. 8.14.2 Lonza Business Overview
  82. 8.14.3 Lonza Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lonza Pharmaceutical BPO Service Product Portfolio
  84. 8.14.5 Lonza Recent Developments
  85. 8.15 Boehringer Ingelheim
  86. 8.15.1 Boehringer Ingelheim Company Information
  87. 8.15.2 Boehringer Ingelheim Business Overview
  88. 8.15.3 Boehringer Ingelheim Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Boehringer Ingelheim Pharmaceutical BPO Service Product Portfolio
  90. 8.15.5 Boehringer Ingelheim Recent Developments
  91. 8.16 Charles Rivers
  92. 8.16.1 Charles Rivers Company Information
  93. 8.16.2 Charles Rivers Business Overview
  94. 8.16.3 Charles Rivers Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Charles Rivers Pharmaceutical BPO Service Product Portfolio
  96. 8.16.5 Charles Rivers Recent Developments
  97. 8.17 Genpact
  98. 8.17.1 Genpact Company Information
  99. 8.17.2 Genpact Business Overview
  100. 8.17.3 Genpact Pharmaceutical BPO Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Genpact Pharmaceutical BPO Service Product Portfolio
  102. 8.17.5 Genpact Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst